×
About 26,915 results

Ketorolac Intravenous Regional Analgesia in Lower Limb Surgeries
https://clinicaltrials.gov/ct2/show/NCT05543785

Mar 15th, 2023 - This is a randomized controlled trial that tests the effecacy of the intravenous regional ketorolac in lower limb orthopedic surgeries with spinal anesthesia. The investigators will compare the effect of 30 mg ketorolac without local anesthetic in the injected intravenously in an isolated lower limb (with torniquet) versus intravenous 30 mg ketorolac administered 10 minutes before toniquet pres...

Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee
https://clinicaltrials.gov/ct2/show/NCT05486026

Mar 14th, 2023 - This will be a 13-week A randomized open labelled clinical trail in Iraqi Kurdistan Region, that will be designed to assess the efficacy of duloxetine tablet compared with other group (Nonsteroidal anti-inflammatory) drug on the reduction of pain caused by osteoarthritis of the knee. Patients will be divided into two groups, first group (case) will receive duloxetine tablet 30mg for two weeks t...

Polarized Dendritic Cell (aDC1) Vaccine, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma
https://clinicaltrials.gov/ct2/show/NCT04093323

Mar 10th, 2023 - PRIMARY OBJECTIVE: I. To evaluate the objective response rate to treatment with an autologous alpha-type-1 polarized dendritic cells (alphaDC1)/TBVA vaccine (alpha-type-1-polarized dendritic cells loaded with tumor blood vessel-targeting antigenic peptides) plus cytokine modulating (CKM) regimen (rintatolimod, recombinant interferon alpha-2 [IFN-alpha2b] and, celecoxib) in human leukocyte antig...

Comparison of the Analgesic Effects of Scalp Nerve Block and Intravenous Ibuprofen Applications Under the Guidance of Nociception Level Index (NoL) in Patients Undergoing Elective Supratentorial Cr...
https://clinicaltrials.gov/ct2/show/NCT05763836

Mar 10th, 2023 - Scalp incision is a powerful nociceptive stimulus that can exacerbate rapid changes in hemodynamic and sympathetic activity. Management of hemodynamic stability is essential in neuro-anesthesia and can be challenging among neurosurgery anesthesiologists. A good anesthetic technique can improve hemodynamic responses by reducing the incidence of complications such as intracranial hypertension, bl...

Parenting Young Children Study
https://clinicaltrials.gov/ct2/show/NCT05180487

Mar 10th, 2023 - Opioid use is rising at unprecedented levels and has reached epidemic proportions in some areas of the country, particularly rural areas. Although research on the detrimental effects of opioid use on parenting and children is relatively new, it is clear that parents with opioid use struggle with a variety of parenting skills, especially contingent responsivity and warmth. As such, to have long-...

DIalysis Symptom COntrol-Pruritus Outcome Trial
https://clinicaltrials.gov/ct2/show/NCT05180968

Mar 10th, 2023 - Several different types of medications are effective in treating uremic pruritus, but even with effective treatments, residual symptoms are common and some medications are not well tolerated. Standard of care treatments include emollients which are lotions that keep the skin hydrated and a variety of pills that target the itch pathways implicated in the disease. The objective of the study is to...

PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy
https://clinicaltrials.gov/ct2/show/NCT05246670

Mar 10th, 2023 - PRIMARY OBJECTIVE: I. To look for evidence of the efficacy of PEA (N-palmitoylethanolamide) at two different doses relative to placebo responses, as a treatment for chemotherapy-induced neuropathy (CIPN). SECONDARY OBJECTIVES: I. To assess the safety of PEA at the two study doses. II. To evaluate changes in patient-reported symptoms and quality of life from baseline to the end of 8 weeks. OUTLI...

A Bioequivalence Study of Advil PM Liqui-Gels Minis (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) Compared to the Current Marketed Advil PM Liqui-Gels (Ibuprofen/Diphenhydramine Hydrochlor...
https://clinicaltrials.gov/ct2/show/NCT05674721

Mar 10th, 2023 - This is a single center, single dose, open-label, randomized, two-treatment, two-sequence, two-period crossover, bioequivalence study in healthy adult participants with at least a 7-day washout period. A sufficient number of participants will be screened to randomize approximately 44 to ensure at least 37 evaluable participants complete the entire study. Participants will be randomly assigned t...

Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
https://clinicaltrials.gov/ct2/show/NCT05514899

Mar 10th, 2023 - This project will characterize the microbiome and endocannabinoid system (ECS) in people with HIV (PWH) and how they relate to neuroinflammation and blood-brain barrier (BBB) function. The study hypothesizes that pathogenic alterations in the gut microbiota (dysbiosis) and impaired gut barrier integrity (leaky gut) are mediators between the ECS, neuroinflammation and BBB dysfunction in HIV. The...

Evaluation of Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty
https://clinicaltrials.gov/ct2/show/NCT05558410

Mar 10th, 2023 - The purpose of this study is to evaluate the efficacy and safety of VX-548 in treating acute pain after an abdominoplasty.

Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy
https://clinicaltrials.gov/ct2/show/NCT05553366

Mar 10th, 2023 - The purpose of this study is to evaluate the efficacy and safety of VX-548 for acute pain after a bunionectomy.

Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket Pain
https://clinicaltrials.gov/ct2/show/NCT05575999

Mar 10th, 2023 - Bupivacaine is a widely used local anesthetic and is often administered by spinal injection prior to major surgical procedures. Ketorolac is a potent NSAID which is used for the short-term relief of moderate to severe pain. It's used for long term duration is generally limited due to its potential to cause GI ulcers/perforation and renal failure. A single dose of perioperative Ketorolac has bee...

Blood Markers of Early Pancreas Cancer
https://clinicaltrials.gov/ct2/show/NCT03568630

Mar 10th, 2023 - Patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) have only an 10% chance of surviving 5 years after diagnosis. Most PDAC is advanced and not amenable to curative therapies at the time of diagnosis, owing to lack of symptoms in early disease, nonspecific symptoms when they do develop resulting in a delay in diagnosis. Identifying biomarkers of early PDAC could facilitate screening...

Natural Language Processing for Screening Opioid Misuse
https://clinicaltrials.gov/ct2/show/NCT05745480

Mar 10th, 2023 - The clinical narrative in the electronic health record (EHR) carries valuable information for predictive analytics, but its free-text form is difficult to mine and analyze for clinical decision support (CDS). Large-scale clinical natural language processing (NLP) pipelines have focused on data warehouse applications for retrospective research efforts. There remains a paucity of evidence for imp...

Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances
https://clinicaltrials.gov/ct2/show/NCT05147376

Mar 10th, 2023 - Patients who require fixed orthodontic appliances as part of their orthodontic treatment at the Faculty of Dentistry, Chulalongkorn University will be asked if they will volunteer for this clinical research. Participants will be informed about the objectives of the study, study process, advantages, disadvantages before making a decision to participate in this study. The consent form will be sig...

A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.
https://clinicaltrials.gov/ct2/show/NCT05025787

Mar 10th, 2023 - The study will employ a randomized, allocation-concealed, multicenter, placebo-controlled, multi-period crossover design (Schmid et al, 2018). This multi-period crossover randomized, controlled trial allows comparability and assessment of efficacy through repeated exposures within each subject to the active treatment and a control (placebo) in randomized sequence. Such multi-period crossover de...

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
https://clinicaltrials.gov/ct2/show/NCT03946111

Mar 10th, 2023 - Obesity is a heterogeneous problem and research has highlighted the particular significance of a subgroup with binge-eating disorder (BED), the most prevalent formal eating disorder. Improved treatments for patients with obesity and BED are needed that can produce sustained clinical outcomes and promote weight loss. This study RCT will provide new and novel findings from a controlled test, amon...

Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
https://clinicaltrials.gov/ct2/show/NCT04804553

Mar 10th, 2023 - The study will aim to estimate the efficacy of apremilast compared with placebo in the treatment of juvenile psoriatic arthritis (JPsA) in pediatric participants 5 to less than 18 years of age.

Buprenorphine Treatment for Opioid Dependence
https://clinicaltrials.gov/ct2/show/NCT02187198

Mar 10th, 2023 - This is a randomized, open-label clinical trial with approximately 9 Veteran opioid dependent men and women. Veterans were randomized to one of two treatment groups: low dose range of buprenorphine (<8mg) vs. high dose range of buprenorphine/naloxone (BUP/NLX (<16mg). During induction into buprenorphine, all participants will be started at a dose of 2mg, and this dose will be increased as neede...

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer
https://clinicaltrials.gov/ct2/show/NCT03186638

Mar 10th, 2023 - PRIMARY OBJECTIVES: I. To provide preliminary data on the effect of ibuprofen on alleviating chemotherapy-related cognitive impairment (CRCI) in cancer patients receiving chemotherapy or who have received chemotherapy within the last 6 months compared to a placebo control, as assessed by the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog). OUTLINE: Patients are randomized ...